Future-Proofing Hubs is a Must. With ongoing policy uncertainty, hubs must prioritize adaptable, resilient designs—focusing ...

Healthcare providers must enhance awareness of counterfeit medicines to protect patients, especially as online drug purchases ...

The biopharma company—whose US headquarters is in Atlanta—will be building a new biologics manufacturing facility in a city ...

Many uninsured and underinsured individuals remain unaware of vital financial assistance programs for prescription costs, ...

In the third part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, shares the ways in which ...

As the rising cost of prescription medications in the United States becomes an increasing barrier for millions of people, how ...

An exploration into how flawed incentives and contractual loopholes between manufacturers and pharmacy benefit managers ...

Reintroduction of the MFN model. The Trump Administration has revived the most-favored nation (MFN) drug pricing model as a ...

In the first part of her Pharma Commerce video interview, Kirsten Newquist, Identiv’s CEO, defines the term, and explains how ...

A recent Pharmaceutical Executive article highlights how antibody-drug conjugates are experiencing a renaissance in oncology, with innovations in targeting, linker technology, and payload design ...

In the final part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, illustrates how data-driven ...

In the third part of her Pharma Commerce video interview, Maggie McCullough, PolicyMap’s CEO, comments on how mobile and ...